provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content

Xpovio

selinexor
Used for Multiple Myeloma
Used for Multiple Myeloma

Xpovio (selinexor) is a targeted therapy medication used to treat multiple myeloma and diffuse large b-cell lymphoma. It's taken by mouth either weekly or twice weekly, depending on what other anticancer medications your provider prescribes. Xpovio (selinexor) can cause side effects such as nausea, bleeding, and confusion. This medication is brand name only.

Last reviewed on August 14, 2023
basics-icon

What is Xpovio (selinexor)?

What is Xpovio (selinexor) used for?

How Xpovio (selinexor) works

One way healthy cells fight cancer is through tumor suppressor proteins, which monitor for and kill cancerous cells before they can grow. Healthy cells shuttle these proteins in and out of the cells using receptors called exportin-1 (XPO-1), depending on whether they’re needed or not.

When cells turn cancerous, some of them end up making a lot of XPO-1. Having too many XPO-1 means that the tumor suppressor proteins end up getting shuttled out, even when they’re needed to fight cancerous cells. This allows the cancer to grow and spread.

Xpovio (selinexor) works by blocking XPO-1. This helps keep these tumor suppressor proteins inside the cell, so they can fight cancer.

Drug Facts

Common BrandsXpovio
Drug ClassXPO1 inhibitor
Controlled Substance ClassificationNot a controlled medication
Generic StatusNo lower-cost generic available
AvailabilityPrescription only
basics-icon

What are the side effects of Xpovio (selinexor)?

The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.

Common Side Effects

  • Low platelet levels (up to 92%)
  • Low blood cell counts (up to 82%)
  • Tiredness (up to 73%)
  • Nausea (up to 72%)
  • Higher blood sugar levels (up to 62%)
  • Changes in lab tests, including protein and electrolyte levels (up to 62%)
  • Lower appetite (up to 53%)
  • Weight loss (up to 47%)
  • Diarrhea (up to 44%)
  • Vomiting (up to 41%)
  • Tingling sensation in the hands and feet (32%)

Other Side Effects

  • Constipation
  • Upper respiratory tract infections
  • Trouble breathing
  • Cataract
  • Fever
  • Blurry vision
  • Dizziness
  • Taste changes
Please note: The side effects reported include those experienced by people who were also taking bortezomib (Velcade) and dexamethasone.

Serious Side Effects

Contact your healthcare provider immediately if you experience any of the following.
  • Severe bleeding: feeling weak, bruising that doesn't go away, bleeding that's hard to stop, nosebleeds, blood in urine, black and tarry stool
  • Serious infections: fever, weakness, tiredness, sore throat, cough, body aches, muscle aches, chills
  • Low sodium level in blood: nausea, vomiting, headache, confusion, muscle weakness or cramps, feeling tired, seizures
  • Serious nervous system problems: confusion, hallucinations, difficulty staying awake, passing out, delirium

Source: DailyMed

The following side effects have also been reported

Side effects that you should report to your care team as soon as possible:

  • Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
  • Change in vision such as blurry vision, seeing halos around lights, vision loss
  • Infection—fever, chills, cough, sore throat, wounds that don't heal, pain or trouble when passing urine, general feeling of discomfort or being unwell
  • Low red blood cell level—unusual weakness or fatigue, dizziness, headache, trouble breathing
  • Low sodium level—muscle weakness, fatigue, dizziness, headache, confusion
  • Pain, tingling, or numbness in the hands or feet, muscle weakness, change in vision, confusion or trouble speaking, loss of balance or coordination, trouble walking, seizures
  • Unusual bruising or bleeding

Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):

pros-and-cons

Pros and cons of Xpovio (selinexor)

thumbs-up

Pros

Recommended treatment option for people with multiple myeloma in people who have had at least one prior therapy

Taken by mouth, so good for people who don’t like needles

Can be taken with or without food, so more convenient

thumbs-down

Cons

Might raise your risk for bleeding and infection

Requires regular lab tests to monitor for side effects, so more appointments

Commonly causes nausea

pharmacist-tips

Pharmacist tips for Xpovio (selinexor)

pharmacist
  • Sometimes, Xpovio (selinexor) can cause low white blood cell (WBC) counts, which means you’re more likely to get sick. You can help prevent infections by washing your hands often, avoiding crowds, and washing raw fruits and vegetables thoroughly before eating them.

    • Check your body temperature regularly, ideally once a day. Call your provider immediately if your temperature is 100.4 degrees Fahrenheit or higher; this means you have a fever. Sometimes a fever might be the only sign that you’re sick.

      • If you develop low platelets while taking Xpovio (selinexor), you’re at higher risk for serious bleeds. Your provider might recommend you avoid taking other medications that can raise your risk of bleeding, such as aspirin or ibuprofen (Advil). You might also avoid shaving with a blade razor, and use an electric razor instead.

        • Some people taking Xpovio (selinexor) experienced low sodium in their blood (hyponatremia). Your provider will monitor your sodium with lab tests, so it’s important you go to appointments as they recommend. If you have any symptoms of low sodium levels such as muscle cramps, severe tiredness, or seizures, seek medical help right away.

          • Take Xpovio (selinexor) around the same time each day. Take the tablets whole and do not crush or split them. If you miss a dose, skip it and wait until the next scheduled dose.

            • If you have leftover medication, ask your provider how to dispose of it. They might allow you or a family member to bring it to their office or clinic for proper disposal.

              • Females taking Xpovio (selinexor)] should avoid breastfeeding during treatment and for 1 week after the last dose. We don’t know whether Xpovio (selinexor)] is found in breastmilk and whether it affects breastfed babies, but there’s a possible risk of harm.

                faqs

                Frequently asked questions about Xpovio (selinexor)

                Is Xpovio (selinexor) chemotherapy?
                No, Xpovio (selinexor) isn't a chemotherapy medication. Chemotherapy works by attacking cells that are growing quickly. Xpovio (selinexor) works in a more specific way and is called targeted therapy. This medication blocks a specific receptor called XPO-1, which stops cancer cells from being able to grow and spread.
                Does Xpovio (selinexor) cause nausea and vomiting?
                Yes, people taking Xpovio (selinexor) often experience nausea. Vomiting is also possible, but it's not as common. You might start to feel nausea or vomiting side effect several days after you take your dose. Your provider will recommend that you take an antiemetic, such as ondansetron (Zofran), before you take your Xpovio (selinexor) dose. They might also recommend other nausea medications to either take with your Xpovio (selinexor) dose, or to take in between doses. If you have nausea and the medications you're taking aren’t working well to manage it, contact your provider.
                What’s the most common side effect of Xpovio (selinexor)?
                The most common side effect of Xpovio (selinexor) is lower platelet levels. Platelets are blood cells that form blood clots. When their levels are low, you might be at higher risk for bleeding that's hard to stop. Your provider will monitor your platelet levels with lab tests while you're taking Xpovio (selinexor). If your levels are too low, they might ask you to pause Xpovio (selinexor) to give your platelets a chance to recover. If your platelet levels continue to be low, your provider might lower your dose of Xpovio (selinexor) or ask you to stop taking this medication altogether. Let your care team know right away if you notice bruising, nosebleeds, blood in urine, and dark or tarry stool.
                What nervous system problems can Xpovio (selinexor) cause?
                Some people taking Xpovio (selinexor) developed problems with their nervous system, including confusion, delirium, hallucinations, dizziness, difficulty staying awake, and passing out. These symptoms usually begin about one month after starting Xpovio (selinexor) treatment. For most people, these symptoms went away after they stopped taking the medication. Because confusion is possible, it’s important for your family or caregiver to know about this side effect, in case they need to help describe your symptoms to your provider. If you have confusion, delirium, trouble staying awake, or experience hallucinations or passing out, contact your provider right away.
                Why should I check my temperature regularly when I’m taking Xpovio (selinexor)?
                Xpovio (selinexor) can lower your white blood cell (WBC) counts. Because WBCs help your body fight infections, having lower WBC levels mean you’re more likely to get sick. Sometimes, fever is the only symptom you’ll have when you’re sick. Your body might not show other signs of infection, like chills or body aches. It’s important to detect infection early, and checking for a fever is one of the best ways to do this. If you have a temperature of 100.4 degrees Fahrenheit or higher, contact your provider right away.
                How long should I take Xpovio (selinexor) for?
                How long you take Xpovio (selinexor) depends on several factors, such as how well the medication is working for you and if you’re having any bothersome or serious side effects. Your provider will monitor how well Xpovio (selinexor) is working for you with lab tests or scans, depending on which type of cancer you have. Don’t stop taking Xpovio (selinexor) without first talking to your provider.
                GoodRxEducationalIcon

                How to save using GoodRx

                Compare Prices
                1. Compare PricesSpecify your dosage and quantity to find out exactly how much you can save.
                Select your free coupon
                2. Select your free couponYou can use the displayed coupon, or compare prices at other pharmacies near you.
                Show coupon to your pharmacist
                3. Show coupon to your pharmacistPresent your printed or electronic coupon when you pick up your prescription.
                Get free couponLearn more
                warings-icon

                What are the risks and warnings for Xpovio (selinexor)?

                Xpovio (selinexor) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.

                risk-warning

                Risk of serious bleeds (from low platelet levels)

                Xpovio (selinexor) commonly causes low platelet levels. This typically happens within the first few months after you start treatment. Platelets are the cells in your blood that form blood clots and prevent bleeding. So, when they’re low, your body can’t stop bleeding as well. Your provider will monitor your blood cell counts regularly while you’re taking Xpovio (selinexor)]. If your platelet levels are too low, your provider might need to stop, pause, or adjust your dose of Xpovio (selinexor)]. If you have signs of low platelets such as bruising, nose bleeds, or blood in stool or urine, contact your provider right away.

                risk-warning

                Low white blood cell counts

                People who take Xpovio (selinexor)] often have low blood cell counts, particularly low white blood cells (neutropenia). White blood cells (WBCs) are an important part of your immune system, so when they’re low you might have a higher risk of serious infections. People tend to notice the drop in WBC count within the first month of treatment. Your provider will regularly monitor your blood cell counts while you’re taking Xpovio (selinexor)], and they might prescribe other medications such as antibiotics or antivirals to protect you from serious infections. You can lower your risk of getting sick by washing your hands often and avoiding crowds. Check your temperature regularly, and call your provider right away if your temperature is 100.4 degrees Fahrenheit or higher.

                risk-warning

                Serious infection

                People taking Xpovio (selinexor) sometimes developed an infection. The most common types were lung infections such as pneumonia, which can be serious. Infection can happen at any time after you start taking Xpovio (selinexor). Additionally, having cancer can mean your immune system doesn’t work as well to fight infections. Because of this, it’s important to contact your provider right away if you have any signs or symptoms of infection such as fever, body aches, chills, cough, or low blood pressure.

                risk-warning

                Nausea, vomiting, and diarrhea

                Most people taking Xpovio (selinexor) experience nausea, vomiting, and diarrhea. Nausea can happen several days after you take your Xpovio (selinexor) dose. It’s recommended that you take an antiemetic, such as ondansetron (Zofran), before receiving your dose. Your provider might also recommend other medications to either take with your Xpovio (selinexor) dose, or to take in between doses. If you have nausea and the medications you have aren’t working well to manage it, contact your provider.

                If you experience diarrhea, your provider might recommend over-the-counter diarrhea medications, like loperamide (Imodium A-D), to help. If you have severe diarrhea that causes dehydration, you might need to receive intravenous (IV) fluids at a hospital.

                If nausea, vomiting, or diarrhea are severe, you might have to pause or stop taking Xpovio (selinexor). Sometimes, these side effects cause people to lose their appetite, which can lead to weight loss. Your provider will likely recommend that you work with a dietician to make sure you get the proper nutrition in your diet.

                risk-warning

                Low sodium levels in the blood

                Some people taking Xpovio (selinexor) experienced low sodium levels in their blood (hyponatremia). This can be serious and lead to seizures and coma if not treated. Your provider will monitor your sodium with lab tests, and if your sodium is too low, you might need to pause Xpovio (selinexor). Sometimes, if your sodium level improves, your provider can restart Xpovio (selinexor), but maybe at a lower dose. Other times, they might ask you to stop taking Xpovio (selinexor) altogether. If you have any symptoms of low sodium levels such as muscle cramps, severe tiredness, or seizures, seek medical help right away.

                risk-warning

                Nervous system problems

                People taking Xpovio (selinexor) can develop problems with their nervous system. Examples include confusion, difficulty staying awake, delirium, hallucinations, dizziness, and passing out. These symptoms usually started around one month after starting Xpovio (selinexor). Most of the time, these symptoms go away after you stop taking Xpovio (selinexor). Because confusion is possible, it’s important for your family or caregiver to know about this side effect, in case they need to help describe your symptoms to your provider. If you have confusion, hallucinations, delirium, trouble staying awake, or pass out, contact your provider right away.

                risk-warning

                Harm to unborn baby

                Based on animal studies, Xpovio (selinexor)] might harm an unborn baby or raise the risk for miscarriage (pregnancy loss) when taken during pregnancy. Because of these risks, if you’re a female who can get pregnant, you should use birth control while taking Xpovio (selinexor)] and for 1 week after the last dose. Your provider might require a negative pregnancy test before you start treatment. Let your provider know right away if you become pregnant while taking Xpovio (selinexor)]. Males who are sexually active with a female who can get pregnant should use birth control such as condoms while taking Xpovio (selinexor) and for 1 week after the last dose.

                risk-warning

                Cataract

                Risk factors: Previous cataract
                Some people taking Xpovio (selinexor) developed a cataract, which is a cloudy spot in your eye that can make it difficult to see. This happened both in people who already had cataracts, and whose symptoms got worse, and also new cataracts developed in people who’d never had one before. This usually happens after you’ve been on Xpovio (selinexor) for several months. If you have any changes or cloudy spots in your vision, contact your provider right away.

                dosage

                Xpovio (selinexor) dosage forms

                Typical dosing for Xpovio (selinexor)

                Multiple myeloma

                • In combination with bortezomib (Velcade) and dexamethasone: The typical dose is 100 mg by mouth weekly (on day 1 of each week).

                • In combination with dexamethasone only: The typical dose is 80 mg by mouth twice weekly (on days 1 and 3 of each week).

                Diffuse large B-cell lymphoma

                • The typical dose is 60 mg by mouth twice weekly (on days 1 and 3 of each week).

                alternatives

                What are alternatives to Xpovio (selinexor)?

                There are a number of medications that your doctor can prescribe in place of Xpovio (selinexor). Compare a few possible alternatives below.
                Xpovio (selinexor)
                Used for:
                Used for:
                Used for:

                Get savings updates for Xpovio (selinexor)

                Receive price alerts, news, and other messages from GoodRx about Xpovio (selinexor) and other healthcare topics and relevant savings offers.

                By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.

                References

                Best studies we found

                American Cancer Society. (2020). Fever.

                American Cancer Society. (2020). Why people with cancer are more likely to get infections.

                American Cancer Society. (2021). How targeted therapies are used to treat cancer.

                View All References (15)

                American Cancer Society. (2023). Low white blood cell counts (neutropenia).

                American Cancer Society. (2024). Nutrition for People With Cancer.

                American Red Cross. (2021). The function of platelets: 5 things you might not know.

                Azizian, N. G., et al. (2020). XPO1-dependent nuclear export as a target for cancer therapy. Journal of Hematology & Oncology.

                Cancer.net. (2019). Safe storage and disposal of cancer medications

                Centers for Disease Control and Prevention. (n.d.). What you need to know: Neutropenia and risk for infection.

                Chaudhury, S., (2010). Hallucinations: Clinical aspects and management. Industrial Psychiatry Journal.

                Cooper, G. M. (2000). Tumor suppressor genes. The Cell: A Molecular Approach, 2nd edition.

                Gavriatopoulou, M., et al. (2020). Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials. Leukemia.

                Karyopharm Therapeutics Inc. (2022). Zpovio- selinexor tablet, film coated [package insert]. DailyMed.

                Lymphoma Research Foundation. (n.d.). Diffuse large B-cell lymphoma.

                National Comprehensive Cancer Network. (2021). Anemia and neutropenia: Low red and white blood cell counts.

                National Comprehensive Cancer Network. (2022). Nausea and vomiting.

                National Kidney Foundation. (n.d.). Hyponatremia (low sodium level in the blood).

                Peterson, T. J., et al. (2020). Selinexor: A first-in-class nuclear export inhibitor for management of multiply relapsed multiple myeloma. The Annals of Pharmacotherapy.

                GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.
                Was this page helpful?

                Browse medications

                View All

                Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.